Zoetis Inc.
ZTS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001555280
No open-market purchases or sales by Zoetis Inc. insiders were filed in the last 90 days; 1,433 institutions reported holding it in 13F filings for Q2 2026, worth $28.6B in total; superinvestors Markel Group and Soros Fund Management hold it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −165 vs. previous quarter
- 1,433
- 13F valueReported value at the end of Q2 2026
- $28.6B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Superinvestors holding ZTS, Q2 2026
2 superinvestors report holding Zoetis Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
Open-market purchases and sales by Zoetis Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 (view filing) | May 13 | Same day | Damelio Frank ADirector | PPurchase | +6.65K | $75.39 | +$501.3K | +44.9%21.5K after | |
| May 13, 2026 (view filing) | May 13 | Same day | Bisaro PaulDirector | PPurchase | +2.00K | $75.88 | +$151.8K | +7.7%27.9K after | |
| May 12, 2026 (view filing) | May 11 | 1 day | McCallister Michael BDirector | PPurchase | +3.00K | $77.76 | +$233.3K | +13.9%24.5K after | |
| Feb 17, 2026 (view filing) | Feb 17 | Same day | Peck Kristin CChief Executive Officer | SSale | −20.0K | $127.05 | −$2.54M | −16.5%101.3K after | 2 lots10b5-1 |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Lagano RoxanneExecutive Vice President | SSale | −652 | $170.00 | −$110.8K | −4.1%15.1K after | 10b5-1 |
| Mar 11, 2025 (view filing) | Mar 10 | 1 day | Lagano RoxanneExecutive Vice President | SSale | −326 | $170.00 | −$55.4K | −2.0%15.8K after | 10b5-1 |
| Mar 11, 2025 (view filing) | Mar 11 | Same day | Reed Willie MDirector | SSale | −1.21K | $166.14 | −$201.0K | −9.7%11.2K after | |
| Feb 20, 2025 (view filing) | Feb 19 | 1 day | Peck Kristin CChief Executive Officer | SSale | −382 | $156.68 | −$59.9K | −0.4%94.2K after | 10b5-1 |
| Feb 11, 2025 (view filing) | Feb 11 | Same day | Lagano RoxanneExecutive Vice President | SSale | −326 | $171.18 | −$55.8K | −2.0%16.1K after | 10b5-1 |
| Nov 26, 2024 (view filing) | Nov 25 | 1 day | Polzer Robert JExecutive Vice President | SSale | −3.48K | $177.46 | −$617.0K | −51.7%3.25K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Zoetis Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 39,430,181 | $2.83B | 0.04% | +3,845,869+10.8% | Added |
| Vanguard Capital Management LLC | 26,027,984 | $1.87B | 0.04% | −44,862−0.2% | Reduced |
| Vanguard Portfolio Management LLC | 23,860,445 | $1.71B | 0.08% | −106,955−0.4% | Reduced |
| State Street Corp | 19,667,723 | $1.41B | 0.04% | +343,322+1.8% | Added |
| State Farm Mutual Automobile Insurance Co | 15,892,903 | $1.14B | 0.78% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 13,289,622 | $951.8M | 0.05% | +1,940,374+17.1% | Added |
| Wellington Management Group LLP | 9,423,895 | $677.2M | 0.12% | −726,201−7.2% | Reduced |
| Morgan Stanley | 8,878,849 | $638.0M | 0.03% | −5,266,886−37.2% | Reduced |
| Nordea Investment Management AB | 6,592,578 | $471.7M | 0.38% | +727,467+12.4% | Added |
| Deutsche Bank AG | 5,851,737 | $420.5M | 0.12% | +319,709+5.8% | Added |